GGT6
gene geneOn this page
Also known as FLJ90165
Summary
GGT6 (gamma-glutamyltransferase 6, HGNC:26891) is a protein-coding gene on chromosome 17p13.2, encoding Glutathione hydrolase 6 (Q6P531). Hydrolyzes and transfers gamma-glutamyl moieties from glutathione and other gamma-glutamyl compounds to acceptors.
GGT6 belongs to the gamma-glutamyltransferase (GGT; EC 2.3.2.2) gene family. GGT is a membrane-bound extracellular enzyme that cleaves gamma-glutamyl peptide bonds in glutathione and other peptides and transfers the gamma-glutamyl moiety to acceptors. GGT is also key to glutathione homeostasis because it provides substrates for glutathione synthesis (Heisterkamp et al., 2008 [PubMed 18357469]).
Source: NCBI Gene 124975 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 104 total
- MANE Select transcript:
NM_001288702
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26891 |
| Approved symbol | GGT6 |
| Name | gamma-glutamyltransferase 6 |
| Location | 17p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ90165 |
| Ensembl gene | ENSG00000167741 |
| Ensembl biotype | protein_coding |
| OMIM | 612341 |
| Entrez | 124975 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 5 protein_coding, 1 retained_intron
ENST00000301395, ENST00000381550, ENST00000573591, ENST00000574154, ENST00000574584, ENST00000575573
RefSeq mRNA: 5 — MANE Select: NM_001288702
NM_001122890, NM_001288702, NM_001288703, NM_001288704, NM_153338
CCDS: CCDS11047, CCDS45582, CCDS73942
Canonical transcript exons
ENST00000381550 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001116300 | 4559558 | 4559760 |
| ENSE00001243152 | 4556927 | 4559057 |
| ENSE00002675679 | 4560382 | 4560577 |
| ENSE00003539682 | 4559343 | 4559456 |
Expression profiles
Bgee: expression breadth ubiquitous, 160 present calls, max score 98.14.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.8102 / max 97.2319, expressed in 125 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 163921 | 0.8007 | 124 |
| 163922 | 0.0095 | 5 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 98.14 | gold quality |
| upper arm skin | UBERON:0004263 | 97.40 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 95.93 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 95.36 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 95.13 | gold quality |
| ileal mucosa | UBERON:0000331 | 94.71 | gold quality |
| parotid gland | UBERON:0001831 | 93.04 | gold quality |
| kidney epithelium | UBERON:0004819 | 92.83 | gold quality |
| skin of abdomen | UBERON:0001416 | 92.05 | gold quality |
| skin of leg | UBERON:0001511 | 91.55 | gold quality |
| esophagus mucosa | UBERON:0002469 | 91.25 | gold quality |
| zone of skin | UBERON:0000014 | 91.02 | gold quality |
| rectum | UBERON:0001052 | 90.25 | gold quality |
| body of pancreas | UBERON:0001150 | 90.15 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 89.95 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 89.54 | gold quality |
| duodenum | UBERON:0002114 | 88.84 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 88.63 | silver quality |
| colonic mucosa | UBERON:0000317 | 88.39 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 88.37 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 88.19 | gold quality |
| minor salivary gland | UBERON:0001830 | 86.78 | gold quality |
| mouth mucosa | UBERON:0003729 | 86.34 | gold quality |
| renal medulla | UBERON:0000362 | 86.28 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 86.20 | gold quality |
| upper leg skin | UBERON:0004262 | 85.76 | gold quality |
| transverse colon | UBERON:0001157 | 85.13 | gold quality |
| mammalian vulva | UBERON:0000997 | 84.94 | gold quality |
| gingival epithelium | UBERON:0001949 | 84.39 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 84.36 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 12.90 |
| E-GEOD-81383 | no | 6.11 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
28 targeting GGT6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-6727-3P | 99.49 | 65.92 | 1333 |
| HSA-MIR-5683 | 99.36 | 68.59 | 2083 |
| HSA-MIR-4722-3P | 99.35 | 65.22 | 1099 |
| HSA-MIR-504-3P | 99.30 | 67.18 | 1745 |
| HSA-MIR-6504-3P | 99.17 | 69.31 | 2891 |
| HSA-MIR-6768-3P | 99.14 | 67.38 | 1319 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
| HSA-MIR-1227-5P | 98.65 | 65.32 | 1549 |
| HSA-MIR-1910-3P | 98.44 | 67.51 | 1695 |
| HSA-MIR-8078 | 98.32 | 65.73 | 361 |
| HSA-MIR-660-3P | 98.14 | 66.04 | 1434 |
| HSA-MIR-3130-5P | 98.14 | 66.00 | 711 |
| HSA-MIR-6511A-5P | 98.13 | 67.47 | 1770 |
| HSA-MIR-6747-3P | 97.73 | 64.84 | 1596 |
| HSA-MIR-4482-5P | 97.53 | 65.68 | 598 |
| HSA-MIR-320E | 97.49 | 65.96 | 865 |
| HSA-MIR-645 | 97.28 | 66.30 | 486 |
| HSA-MIR-552-3P | 96.68 | 64.12 | 1026 |
Literature-anchored findings (GeneRIF, showing 1)
- Variants of GGT6 were associated with rheumatoid arthritis in an Arab population. (PMID:28118524)
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ggt6 | ENSMUSG00000040471 |
| rattus_norvegicus | Ggt6 | ENSRNOG00000015210 |
| drosophila_melanogaster | CG17636 | FBGN0025837 |
| drosophila_melanogaster | CG1492 | FBGN0030361 |
| drosophila_melanogaster | CG4829 | FBGN0030796 |
| drosophila_melanogaster | Ggt-1 | FBGN0030932 |
| caenorhabditis_elegans | WBGENE00012416 | |
| caenorhabditis_elegans | C53D5.5 | WBGENE00016906 |
Paralogs (6): GGT5 (ENSG00000099998), GGT1 (ENSG00000100031), GGTLC2 (ENSG00000100121), GGT7 (ENSG00000131067), GGTLC1 (ENSG00000149435), GGTLC3 (ENSG00000274252)
Protein
Protein identifiers
Glutathione hydrolase 6 — Q6P531 (reviewed: Q6P531)
Alternative names: Gamma-glutamyltransferase 6, Gamma-glutamyltranspeptidase 6
All UniProt accessions (4): B4DPG6, Q6P531, I3L2G6, J3KPJ0
UniProt curated annotations — full annotation on UniProt →
Function. Hydrolyzes and transfers gamma-glutamyl moieties from glutathione and other gamma-glutamyl compounds to acceptors.
Subunit / interactions. Heterodimer composed of the light and heavy chains. The active site is located in the light chain.
Subcellular location. Membrane.
Post-translational modifications. Cleaved by autocatalysis into a large and a small subunit and the autocatalytic cleavage is essential to the functional activation of the enzyme.
Pathway. Sulfur metabolism; glutathione metabolism.
Similarity. Belongs to the gamma-glutamyltransferase family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6P531-1 | 1 | yes |
| Q6P531-2 | 2 |
RefSeq proteins (5): NP_001116362, NP_001275631, NP_001275632, NP_001275633, NP_699169 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029055 | Ntn_hydrolases_N | Homologous_superfamily |
| IPR043137 | GGT_ssub_C | Homologous_superfamily |
| IPR052688 | Gamma-glutamyltransfase | Family |
Pfam: PF01019
Catalyzed reactions (Rhea), 3 shown:
- an N-terminal (5-L-glutamyl)-[peptide] + an alpha-amino acid = 5-L-glutamyl amino acid + an N-terminal L-alpha-aminoacyl-[peptide] (RHEA:23904)
- glutathione + H2O = L-cysteinylglycine + L-glutamate (RHEA:28807)
- an S-substituted glutathione + H2O = an S-substituted L-cysteinylglycine + L-glutamate (RHEA:59468)
UniProt features (15 total): region of interest 3, chain 2, glycosylation site 2, sequence variant 2, topological domain 2, compositionally biased region 2, splice variant 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6P531-F1 | 70.43 | 0.37 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 161, 370
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-174403 | Glutathione synthesis and recycling |
| R-HSA-5423646 | Aflatoxin activation and detoxification |
| R-HSA-9753281 | Paracetamol ADME |
MSigDB gene sets: 77 (showing top):
REACTOME_BIOLOGICAL_OXIDATIONS, GOBP_LEUKOTRIENE_BIOSYNTHETIC_PROCESS, GOBP_ORGANIC_ACID_BIOSYNTHETIC_PROCESS, GOBP_PEPTIDE_METABOLIC_PROCESS, GOBP_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS, GOBP_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS, KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM, GOBP_AMIDE_METABOLIC_PROCESS, GOBP_NONRIBOSOMAL_PEPTIDE_BIOSYNTHETIC_PROCESS, GOBP_AMIDE_BIOSYNTHETIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_ORGANIC_ACID_METABOLIC_PROCESS, LYF1_01, REACTOME_GLUTATHIONE_CONJUGATION, GOBP_LIPID_BIOSYNTHETIC_PROCESS
GO Biological Process (3): glutathione biosynthetic process (GO:0006750), leukotriene D4 biosynthetic process (GO:1901750), glutathione metabolic process (GO:0006749)
GO Molecular Function (6): glutathione gamma-glutamate hydrolase (GO:0036374), obsolete leukotriene C4 gamma-glutamyl transferase activity (GO:0103068), protein binding (GO:0005515), transferase activity (GO:0016740), acyltransferase activity (GO:0016746), hydrolase activity (GO:0016787)
GO Cellular Component (2): membrane (GO:0016020), extracellular exosome (GO:0070062)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Glutathione conjugation | 1 |
| Biological oxidations | 1 |
| Drug ADME | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| sulfur compound biosynthetic process | 2 |
| catalytic activity | 2 |
| glutathione metabolic process | 1 |
| nonribosomal peptide biosynthetic process | 1 |
| modified amino acid biosynthetic process | 1 |
| leukotriene biosynthetic process | 1 |
| fatty acid derivative biosynthetic process | 1 |
| modified amino acid metabolic process | 1 |
| sulfur compound metabolic process | 1 |
| omega peptidase activity | 1 |
| threonine-type peptidase activity | 1 |
| binding | 1 |
| transferase activity | 1 |
| cellular anatomical structure | 1 |
| extracellular vesicle | 1 |
Protein interactions and networks
STRING
774 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GGT6 | GGTLC2 | Q14390 | 848 |
| GGT6 | GGTLC1 | Q9BX51 | 844 |
| GGT6 | GGTLC3 | B5MD39 | 801 |
| GGT6 | ALPG | P10696 | 772 |
| GGT6 | GOT1L1 | Q8NHS2 | 733 |
| GGT6 | ALPI | P09923 | 670 |
| GGT6 | ALPP | P05187 | 665 |
| GGT6 | NPEPPS | P55786 | 638 |
| GGT6 | LDHAL6B | Q9BYZ2 | 635 |
| GGT6 | GOT1 | P17174 | 634 |
| GGT6 | LDHAL6A | Q6ZMR3 | 633 |
| GGT6 | LDHC | P07864 | 630 |
| GGT6 | ALPL | P05186 | 592 |
| GGT6 | GGT5 | P36269 | 532 |
| GGT6 | GOT2 | P00505 | 503 |
IntAct
30 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GGT6 | FAM3C | psi-mi:“MI:0915”(physical association) | 0.560 |
| GGT6 | TMBIM1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ADAM33 | GGT6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BMP10 | GGT6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GGT6 | FAIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GGT6 | GRINA | psi-mi:“MI:0915”(physical association) | 0.560 |
| ENTPD3 | GGT6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GGT6 | SEC22A | psi-mi:“MI:0915”(physical association) | 0.560 |
| GGT6 | TNMD | psi-mi:“MI:0915”(physical association) | 0.560 |
| CUL4A | DDX39A | psi-mi:“MI:0914”(association) | 0.350 |
| FAM3C | GGT6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TNMD | GGT6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SEC22A | GGT6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMBIM1 | GGT6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ADAM33 | GGT6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| BMP10 | GGT6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FAIM2 | GGT6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GRINA | GGT6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ENTPD3 | GGT6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GGT6 | hpaE | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (14): GGT6 (Reconstituted Complex), GGT6 (Affinity Capture-MS), GGT6 (Affinity Capture-MS), GGT6 (Two-hybrid), GGT6 (Two-hybrid), GGT6 (Two-hybrid), GGT6 (Two-hybrid), GGT6 (Two-hybrid), GGT6 (Two-hybrid), ENTPD3 (Two-hybrid), GRINA (Two-hybrid), FAM3C (Two-hybrid), GGT6 (Positive Genetic), FAM19A2 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A1B0GTW7, A0A286YEC0, A6NE52, A7YWM1, D3ZT86, D3ZVB0, G7PWZ3, O08852, O77755, P05111, P07994, P17490, P20863, P27106, P29474, P49000, P98161, Q04997, Q05932, Q16671, Q28680, Q3TAP4, Q4TUC0, Q5TJE4, Q62893, Q6IE08, Q6P531, Q6PDE7, Q6QNU9, Q6ZS72, Q76MJ5, Q7M733, Q7TQH7, Q7Z4F1, Q866Y3, Q8IZF5, Q8K0R6, Q8K592, Q8R2S1, Q8VCS0
Diamond homologs: A7YWM1, P07314, Q0V8L2, Q60928, Q6IE08, Q6P531, Q6PDE7, Q8VYW6, Q99JP7, Q99MZ4, Q9UJ14, A6NGU5, B5MD39, B8NM71, D4B387, O14194, P0DPU3, P0DPU6, P15557, P18956, P19440, P20735, P36267, P36268, Q05053, Q05902, Q14390, Q51693, Q680I5, Q9BX51, Q9CAR5, Q9I406, Q9M0G0, Q9QWE9, Q9US04, Q9Z2A9, A6T9C8, O05218
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
104 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 89 |
| Likely benign | 11 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
372 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:4560378:TTAC:T | donor_loss | 1.0000 |
| 17:4560379:TAC:T | donor_loss | 1.0000 |
| 17:4560380:A:AC | donor_gain | 1.0000 |
| 17:4560381:C:CT | donor_gain | 1.0000 |
| 17:4560381:CCT:C | donor_gain | 1.0000 |
| 17:4559345:AGC:A | donor_gain | 0.9900 |
| 17:4559345:AGCC:A | donor_gain | 0.9900 |
| 17:4559452:TGTGG:T | acceptor_gain | 0.9900 |
| 17:4559552:A:AC | donor_gain | 0.9900 |
| 17:4559553:C:CC | donor_gain | 0.9900 |
| 17:4559556:A:AT | donor_loss | 0.9900 |
| 17:4559761:C:CC | acceptor_gain | 0.9900 |
| 17:4559762:T:A | acceptor_loss | 0.9900 |
| 17:4560377:CTTA:C | donor_gain | 0.9900 |
| 17:4560380:AC:A | donor_gain | 0.9900 |
| 17:4560381:CC:C | donor_gain | 0.9900 |
| 17:4560381:CCTG:C | donor_gain | 0.9900 |
| 17:4560381:CCTGG:C | donor_gain | 0.9900 |
| 17:4559338:CTGA:C | donor_loss | 0.9800 |
| 17:4559339:TGACC:T | donor_loss | 0.9800 |
| 17:4559340:GACCT:G | donor_loss | 0.9800 |
| 17:4559341:A:C | donor_loss | 0.9800 |
| 17:4559345:AG:A | donor_gain | 0.9800 |
| 17:4559454:TGG:T | acceptor_gain | 0.9800 |
| 17:4559457:C:CC | acceptor_gain | 0.9800 |
| 17:4559553:CTGA:C | donor_gain | 0.9800 |
| 17:4559758:TTC:T | acceptor_gain | 0.9800 |
| 17:4560379:TACC:T | donor_gain | 0.9800 |
| 17:4559056:ACCT:A | acceptor_loss | 0.9700 |
| 17:4559058:CT:C | acceptor_loss | 0.9700 |
AlphaMissense
3134 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:4558858:G:C | F213L | 0.977 |
| 17:4558858:G:T | F213L | 0.977 |
| 17:4558860:A:G | F213L | 0.977 |
| 17:4559565:G:C | S112R | 0.966 |
| 17:4559565:G:T | S112R | 0.966 |
| 17:4559567:T:G | S112R | 0.966 |
| 17:4558859:A:G | F213S | 0.939 |
| 17:4558859:A:C | F213C | 0.912 |
| 17:4558871:G:T | A209D | 0.909 |
| 17:4559043:C:G | G152R | 0.909 |
| 17:4559403:C:G | D127H | 0.901 |
| 17:4558790:C:G | C236S | 0.896 |
| 17:4558791:A:T | C236S | 0.896 |
| 17:4559047:A:C | F150L | 0.896 |
| 17:4559047:A:T | F150L | 0.896 |
| 17:4559049:A:G | F150L | 0.896 |
| 17:4559393:A:T | V130D | 0.888 |
| 17:4558903:C:A | W198C | 0.887 |
| 17:4558903:C:G | W198C | 0.887 |
| 17:4558916:C:T | G194D | 0.886 |
| 17:4558916:C:A | G194V | 0.883 |
| 17:4559402:T:A | D127V | 0.882 |
| 17:4558744:G:C | N251K | 0.880 |
| 17:4558744:G:T | N251K | 0.880 |
| 17:4558248:C:G | G417R | 0.872 |
| 17:4558248:C:T | G417R | 0.872 |
| 17:4559400:C:G | A128P | 0.871 |
| 17:4559401:A:C | D127E | 0.867 |
| 17:4559401:A:T | D127E | 0.867 |
| 17:4558378:A:C | F373L | 0.866 |
dbSNP variants (sampled 300 via entrez): RS1000454827 (17:4560961 G>A,T), RS1001384175 (17:4557519 T>C), RS1001450481 (17:4556616 G>A), RS1001573915 (17:4561830 C>T), RS1001734713 (17:4556807 G>A,C), RS1002803380 (17:4561941 T>C), RS1003454601 (17:4559198 G>A,C,T), RS1003531361 (17:4555829 C>T), RS1003709593 (17:4556104 A>G,T), RS1004867923 (17:4560398 G>A), RS1005275588 (17:4557798 A>G,T), RS1005295281 (17:4556182 C>T), RS1005406108 (17:4555977 A>C,T), RS1005465461 (17:4561590 G>A), RS1005763562 (17:4561754 G>A,C,T)
Disease associations
OMIM: gene MIM:612341 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004172_3 | Rheumatoid arthritis | 7.000000e-07 |
| GCST004174_3 | Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive) | 6.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007791 | rheumatoid factor seropositivity measurement |
| EFO:0007837 | anti-citrullinated protein antibody seropositivity |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 2 |
| (+)-JQ1 compound | decreases expression | 2 |
| Air Pollutants | affects methylation, increases abundance, decreases expression | 2 |
| Estradiol | affects cotreatment, decreases expression, increases expression | 2 |
| Particulate Matter | decreases expression, increases abundance, affects methylation | 2 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| butyraldehyde | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| nutlin 3 | increases expression, affects cotreatment | 1 |
| Acetaminophen | increases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cannabidiol | decreases expression | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| Nitrogen Dioxide | affects methylation, increases abundance | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Copper Sulfate | increases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.